CPT code 90581 designates an anthrax vaccine administered via injection to protect against anthrax, a rare but potentially severe bacterial infection. As a vaccine product code, it is relevant for public health immunization programs, occupational health for at-risk populations, and preparedness efforts for biological threats. Nationally, anthrax vaccination is a specialized preventive service with implications for clinical protocols, coverage determinations, and vaccine supply logistics.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context and typical service settings, followed by benchmark and policy-focused sections that address coverage patterns, billing considerations, and coding practice implications. The publication outlines payer coverage approaches, claims processing notes, and common modifier usage where applicable. It also highlights issues important for immunization programs and employers managing occupational exposures.

This summary provides a national perspective on the clinical purpose and administrative handling of CPT code 90581, helping billing professionals, policy analysts, and health administrators understand where the code fits within vaccine delivery and payer reimbursement frameworks. Data not available in the input will be noted within relevant sections.